4ISG | Human glucokinase in complex with novel activator (2S)-3-cyclohexyl-2-[4-(methylsulfonyl)-2-oxopiperazin-1-yl]-N-(1,3-thiazol-2-yl)propanamide | date | 2013-01-16 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Hosfield, D., Skene, R.J. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.65 | ||||||||||||
ligand | 1FY, GLC, IOD | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Design, synthesis and SAR of novel glucokinase activators., Cheruvallath ZS, Gwaltney SL 2nd, Sabat M, Tang M, Feng J, Wang H, Miura J, Guntupalli P, Jennings A, Hosfield D, Lee B, Wu Y, Bioorg Med Chem Lett. 2013 Apr 1;23(7):2166-71. doi: 10.1016/j.bmcl.2013.01.093. , Epub 2013 Feb 4. PMID:23434031 |
Data retrieval |
View 4ISG in 3D |
Visual 3D analysis of 4ISG |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4ISG |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |